EA201492106A1 - Способ и устройство для контроля экстракорпоральной обработки крови пациента - Google Patents

Способ и устройство для контроля экстракорпоральной обработки крови пациента

Info

Publication number
EA201492106A1
EA201492106A1 EA201492106A EA201492106A EA201492106A1 EA 201492106 A1 EA201492106 A1 EA 201492106A1 EA 201492106 A EA201492106 A EA 201492106A EA 201492106 A EA201492106 A EA 201492106A EA 201492106 A1 EA201492106 A1 EA 201492106A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dialysis
patient
light emitted
fluid
fluorescence light
Prior art date
Application number
EA201492106A
Other languages
English (en)
Other versions
EA028556B1 (ru
Inventor
Альфред Гагель
Андреас Майерхофер
Original Assignee
Фрезениус Медикал Кеэ Дойчланд Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фрезениус Медикал Кеэ Дойчланд Гмбх filed Critical Фрезениус Медикал Кеэ Дойчланд Гмбх
Publication of EA201492106A1 publication Critical patent/EA201492106A1/ru
Publication of EA028556B1 publication Critical patent/EA028556B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14558—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters by polarisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6866—Extracorporeal blood circuits, e.g. dialysis circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7225—Details of analog processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1603—Regulation parameters
    • A61M1/1605—Physical characteristics of the dialysate fluid
    • A61M1/1609—Physical characteristics of the dialysate fluid after use, i.e. downstream of dialyser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3403—Regulation parameters
    • A61M1/3406—Physical characteristics of the filtrate, e.g. urea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3306—Optical measuring means

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Signal Processing (AREA)
  • Power Engineering (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

Настоящее изобретение относится к способу контроля экстракорпоральной обработки крови пациента, предпочтительно контроля лечения пациента диализом, гемодиализом, гемодиафильтрацией, гемофильтрацией, и/или лечения пациента перитонеальным диализом, включающему следующие этапы, согласно которым облучают образец диализирующей текучей среды, используемый при лечении диализом с использованием линейно поляризованного облучающего света, измеряют интенсивность света флуоресценции, излучаемого диализирующей текучей средой в первой плоскости поляризации, измеряют интенсивность света флуоресценции, излучаемого диализирующей текучей средой во второй плоскости поляризации, отличной от первой плоскости поляризации, определяют анизотропию света флуоресценции, излучаемого диализирующей текучей средой, и определяют концентрацию по меньшей мере одного флуорофора в диализирующей текучей среде на основании определенного значения анизотропии и интенсивности света флуоресценции, излучаемого диализирующей текучей средой.
EA201492106A 2012-06-15 2013-06-14 Способ и устройство для контроля экстракорпоральной обработки крови пациента EA028556B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261660016P 2012-06-15 2012-06-15
EP12172251.6A EP2674103A1 (en) 2012-06-15 2012-06-15 Method and device for monitoring an extracorporeal blood treatment of a patient
PCT/EP2013/062366 WO2013186357A1 (en) 2012-06-15 2013-06-14 Method and device for monitoring an extracorporeal blood treatment of a patient

Publications (2)

Publication Number Publication Date
EA201492106A1 true EA201492106A1 (ru) 2015-05-29
EA028556B1 EA028556B1 (ru) 2017-11-30

Family

ID=46465026

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201492106A EA028556B1 (ru) 2012-06-15 2013-06-14 Способ и устройство для контроля экстракорпоральной обработки крови пациента

Country Status (11)

Country Link
US (1) US10010289B2 (ru)
EP (2) EP2674103A1 (ru)
JP (1) JP6242883B2 (ru)
KR (1) KR102058260B1 (ru)
CN (1) CN104363820B (ru)
AU (1) AU2013276453B2 (ru)
BR (1) BR112014031407B1 (ru)
CA (1) CA2876542C (ru)
EA (1) EA028556B1 (ru)
IN (1) IN2015DN00165A (ru)
WO (1) WO2013186357A1 (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
JP6049685B2 (ja) 2011-03-23 2016-12-21 ネクステージ メディカル インコーポレイテッド 腹膜透析使い捨てユニット、コントローラ、腹膜透析システム
JP6303555B2 (ja) * 2014-02-04 2018-04-04 株式会社ジェイ・エム・エス アルブミン濃度測定装置及びアルブミン濃度測定方法
US10525182B2 (en) 2014-10-10 2020-01-07 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
JP6595204B2 (ja) * 2015-04-24 2019-10-23 株式会社島津製作所 光学分析装置
EP3432785B1 (en) * 2016-03-25 2021-03-10 The General Hospital Corporation Polarization-based fluorescent nucleic acid detection
EP4052737A1 (en) 2016-07-18 2022-09-07 NxStage Medical Inc. Flow balancing devices, methods, and systems
WO2018045102A1 (en) 2016-08-30 2018-03-08 Nxstage Medical, Inc. Parameter monitoring in medical treatment systems
US11826545B2 (en) 2016-09-08 2023-11-28 Fresenius Medical Care Holdings, Inc. Optical blood detection system
CN111183343A (zh) * 2017-10-06 2020-05-19 生物辐射实验室股份有限公司 蛋白质定量设备
JP6997582B2 (ja) * 2017-10-17 2022-01-17 日機装株式会社 血液浄化装置
CA3092575A1 (en) 2018-02-28 2019-09-06 Nxstage Medical, Inc. Fluid preparation and treatment devices, methods, and systems
WO2020056808A1 (zh) * 2018-09-21 2020-03-26 北京大学深圳医院 血液中吲哚氰绿的检测装置及系统
CN113994193A (zh) * 2019-06-26 2022-01-28 旭化成医疗株式会社 浓度计算装置和血液处理系统
CN110691153B (zh) * 2019-08-27 2020-09-22 珠海格力电器股份有限公司 一种显示模组及终端
US20220152282A1 (en) * 2020-11-13 2022-05-19 Fresenius Medical Care Holdings, Inc. Systems and methods for analyzing spent dialysate
DE102021113519A1 (de) * 2021-05-26 2022-12-01 B.Braun Avitum Ag Optischer Sensor zur Bestimmung einer Dialysedosis
CN116327188B (zh) * 2023-05-29 2023-09-08 深圳市亿米生命科技有限公司 一种基于指夹式血氧仪的血氧分析方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496722A (en) * 1981-05-01 1985-01-29 The Children's Medical Center Corporation Reporter compounds
US5515864A (en) 1994-04-21 1996-05-14 Zuckerman; Ralph Method and apparatus for the in vivo measurement of oxygen concentration levels by the indirect determination of fluoescence lifetime
CA2332833A1 (en) * 1998-05-19 1999-11-25 Spectrx, Inc. Apparatus and method for determining tissue characteristics
JP2002098638A (ja) * 2000-09-26 2002-04-05 Shimadzu Corp 蛍光偏光度測定装置
WO2003063929A1 (en) * 2002-01-28 2003-08-07 Debiotech S.A. Peritoneal dialysis system
US7326576B2 (en) 2003-04-09 2008-02-05 Prescient Medical, Inc. Raman spectroscopic monitoring of hemodialysis
DE102005001051B4 (de) 2005-01-07 2007-10-31 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Erkennung von Komplikationen während einer extrakorporalen Blutbehandlung
DE102006029899B4 (de) 2006-06-29 2009-06-04 Fresenius Medical Care Deutschland Gmbh Spektroskopischer Detektor und Verfahren zur Bestimmung von Blut und biologischen Markersubstanzen in Flüssigkeiten
US20080225265A1 (en) 2007-03-17 2008-09-18 Mi Research, Inc. Method and apparatus for finding macromolecule crystallization conditions
US20110188043A1 (en) * 2007-12-26 2011-08-04 Yissum, Research Development Company of The Hebrew University of Jerusalem, Ltd. Method and apparatus for monitoring processes in living cells
ES2372563T5 (es) 2009-02-11 2022-06-14 Braun Avitum Ag Dispositivo para el tratamiento extracorporal de sangre
US20130153474A1 (en) 2010-06-11 2013-06-20 B. Braun Avitum Ag Apparatus for extracorporeal blood treatment, comprising a measuring device for determining the luminescence of the spent dialysate

Also Published As

Publication number Publication date
CA2876542C (en) 2020-08-18
CN104363820B (zh) 2019-07-05
AU2013276453A1 (en) 2015-01-22
WO2013186357A1 (en) 2013-12-19
KR102058260B1 (ko) 2019-12-20
AU2013276453B2 (en) 2017-08-17
IN2015DN00165A (ru) 2015-06-12
JP2015521492A (ja) 2015-07-30
BR112014031407B1 (pt) 2021-12-28
CN104363820A (zh) 2015-02-18
US20140046150A1 (en) 2014-02-13
BR112014031407A2 (pt) 2017-06-27
EA028556B1 (ru) 2017-11-30
US10010289B2 (en) 2018-07-03
EP2861127A1 (en) 2015-04-22
EP2861127B1 (en) 2020-09-09
KR20150024405A (ko) 2015-03-06
EP2674103A1 (en) 2013-12-18
JP6242883B2 (ja) 2017-12-06
CA2876542A1 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
EA201492106A1 (ru) Способ и устройство для контроля экстракорпоральной обработки крови пациента
EA201391216A1 (ru) Способ и установка для контроля лечения пациента, предпочтительно для контроля гемодиализа, гемодиафильтрации и/или перитонеального диализа
IN2012DN00732A (ru)
JP6139529B2 (ja) 透析液流制御
BR112013003122A2 (pt) aparelho para tratamento extracorpóreo de sangue
EA201201284A1 (ru) Система для обработки крови
MX2009012955A (es) Soluciones, dializados y metodos relacionados.
ATE477824T1 (de) Vorrichtung zur bestimmung des reduktionsverhältnisses oder des kt/v- verhältnisses einer nierenersatzbehandlung
EA201591149A1 (ru) Способ гемодиафильтрации
WO2011132046A3 (en) Dialysis apparatus and method for controlling a dialysis apparatus
MX2015012556A (es) Sistema y metodo para intercambio de dialisis peritoneal teniendo una unidad energizante reutilizable.
DE502004011128D1 (de) Blutbehandlungsvorrichtung
DK1217379T3 (da) Dialyseapparat til bestemmelse af ionkoncentrationen i blod
WO2010115621A3 (de) Vorrichtung und verfahren zur messung eines blutbestandteils im blut für eine extrakorporale blutbehandlungsvorrichtung
TR201907067T4 (tr) Ekstrakorporeal kan tedavisine yönelik cihaz.
WO2014097115A3 (en) An apparatus for extracorporeal blood treatment.
NZ602996A (en) Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
BR112012031252A2 (pt) aparelho para tratamento extracorpóreo de sangue
ATE420678T1 (de) Dialysemaschine mit einer einrichtung zur bestimmung der dialysedosis
EA201171405A1 (ru) Способ и устройство для оптимизации экстракорпоральной обработки крови
EA201500722A1 (ru) Устройство и способ для удаления белково-связанных токсинов из крови пациентов с использованием высокочастотного электромагнитного поля и электростатического поля постоянного тока
BR112013007046A2 (pt) método para a otimização do consumo de dialisato em uma unidade de tratamento sanguíneo e aparato para o tratamento sanguíneo
BR112012033625A2 (pt) método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico
RU2013127665A (ru) Раствор для первичного заполнения аппарата искусственного кровообращения
CY1124001T1 (el) Υγρο αιμοκαθαρσης απαλλαγμενο απο ασβεστιο

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM